WHO To Compensate Those Who Suffered From COVAX Vaccine Side Effects

The World Health Organisation has agreed to a no-fault compensation plan for claims of serious side effects in people in 92 poorer countries that are yet to get COVID-19 vaccines via the COVAX sharing scheme, resolving a big concern among recipient governments.

This is revealed in a statement posted on the WHO website.

According to the statement, the new programme makes compensation available to eligible individuals in 92 low- and middle-income countries without need to resort to law courts, PUNCH Healthwise reports.

This is the first and only global vaccine injury compensation mechanism, and the programme is funded by a small levy on each dose supported by the Gavi COVAX AMC.

The programme operates on an international scale, and will offer eligible people “a fast, fair, robust and transparent process.”

“As the first and only vaccine injury compensation mechanism operating on an international scale, the programme will offer eligible individuals in AMC-eligible countries and economies a fast, fair, robust and transparent process to receive compensation for rare but serious adverse events associated with COVAX-distributed vaccines until 30 June, 2022.

“By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process,” the statement said.

Questions of how compensation claims would be handled in the event of any serious COVID-19 vaccine side effects, which are likely to be very rare, had been a worry for countries due to get COVID-19 shots via the COVAX plan.

Countries funding their own COVID-19 vaccine procurement also plan their own liability programmes.

The WHO-agreed plan, which has been under discussion for several months, is designed to cover serious side effects linked to any COVAX-distributed vaccines until June 30, 2022, to COVAX’s Advance Market Commitment-eligible economies – a group of 92 poorer states which includes most African and Southeast Asian countries.

“It helps those in countries who might have such effects, manufacturers to roll out vaccines to countries faster, and is a key benefit for lower-income governments procuring vaccines through COVAX,” Berkley said.

The WHO said it was also working with the insurance firm Chubb to secure insurance coverage for the programme.